Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

What is the Tumor Microenvironment?

Why are Cancer Cell Lines Useful?

Cancer Classification

Hot vs Cold: the differences between tumor types

Assay for Monitoring and Treating Malignant Brain Tumors

Cutaneous Manifestations of Internal Malignancy

Microfluidic cancer treatment screen combined with flow cytometry

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

Hypoxia Markers and Their Importance

What is Cancer?

What is Immunochemotherapy?

See more featured articles »

Overview of Cell Viability and Cytotoxicity

Insights into Oncofertility

Investigating the Molecular Mechanisms of Cancer

Cancer Management

Targeted Cancer Therapies

Metastatic Migration in Cancer may be Influenced by Metabolism

The Biochemistry of Breast Cancer Screening

Effects of Social and Economic Deprivation on Cancer Mortality

Caring for a Loved One with Cancer

What is Tumorigenesis?

What is Cancer of Unknown Primary?

The Cancer Cell Surface Proteome as a Therapeutic Target

Insight into Cancer Vaccines

Exploiting Enzymes in Cancer Diagnosis and Therapy

Cancer History

Cancer Pain Management

Cancer Prognosis

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

Cancer Pathophysiology

Cancer Symptoms

British Pioneers in Cancer Biology

Using Biomarkers to Detect Cancer

Cancer Pain

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

Pediatric Cancer

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

Cancer Prevention: Lowering your Risk

What Role do Biobanks Play in Cancer Research?

Secondary Lung Cancer

TARDIS: The Improved Method of Detecting Breast Cancer

Cancer Diagnosis

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

Living with Cancer Pain

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

What Causes Cancer?

Myc Mutations and Cancer

Is Cancer a Metabolic Disorder?

Acidosis and Tumor Progression

Cancer Research

Transforming Cancer Care through Genomic Testing

CDK9 and Cancer

Extracellular Vesicles as Floating Cancer Biomarkers

Cancer Screening Considerations: Balancing the Benefits and Risks

Secondary Brain Cancer

Cancer Epidemiology

Cancer Glossary

The Effects of Cancer on Family Life

What is Merkel Cell Carcinoma?

Latest Cancer News and Research

Genetically-modified hookworms successfully deliver medicine to animal hosts

Hookworms, intestinal parasites that infect hundreds of millions of people in under-resourced tropical regions around the globe, have evolved to survive inside the human gut for years, secreting molecules that enable co-existence with their hosts.

3 Jun 2026

TikTok promotes a thriving illicit vaping culture among young people

TikTok videos glamorizing illicit vaping highlight challenges in public health communication, as youth engage more with social media than educational resources.

3 Jun 2026

New study links primary infertility to accelerated reproductive aging

The average woman spends more than one-third of her life in menopause. Some women, however, must deal with menopause-related symptoms longer and face added health problems because of premature menopause (before age 40) or early menopause (before age 45).

3 Jun 2026

ELRIG unveils keynote speakers for Drug Discovery 2026

ELRIG, a not-for-profit, volunteer-led organization dedicated to the global drug discovery community, today announced the keynote speaker program for Drug Discovery 2026.

From ELRIG (UK) Ltd. 3 Jun 2026

90-120 weekly minutes of strength training linked to lower risk of death

Clocking up 90 to 120 weekly minutes of strength (resistance) training may be the sweet spot for lowering the risk of death, suggests a 30 year study, published online in the British Journal of Sports Medicine.

2 Jun 2026

New PET imaging platform improves osteosarcoma surgery precision

A new end-to-end PET imaging approach for osteosarcoma can rapidly and reliably distinguish tumor tissue from normal tissue and accurately assess surgical margins in real time.

2 Jun 2026

Three-drug strategy forces pancreatic tumors into lasting regression

A triple-targeted preclinical therapy combining daraxonrasib, afatinib, and SD36 drove durable pancreatic cancer regression by blocking KRAS/RAS, EGFR/HER2, and STAT3 signaling. The approach prevented treatment resistance across mouse and human tumor-derived models, but remains preclinical and requires more clinically suitable drug combinations before human testing.

2 Jun 2026

Is any level of alcohol safe? Major review reveals where drinking risks rise

This Burden of Proof review found that alcohol consumption is associated with higher risks for several cancers, liver disease, pancreatitis, lower respiratory infections, tuberculosis, and atrial fibrillation. Although low-to-moderate drinking showed modest observational links with lower risks of type 2 diabetes, dementia, and some cardiovascular outcomes, the evidence was weaker and potentially biased.

2 Jun 2026

New AI tool cuts breast cancer biopsy wait times

Women with abnormal mammograms often have to wait for weeks to find out whether they have breast cancer.

2 Jun 2026

Gladstone receives NIAID grant to establish the Center for PhAIge Therapy

When a bacterial infection stops responding to antibiotics, doctors have few options to treat it. Phages-viruses that naturally infect and kill bacteria-have long intrigued clinicians as a potential weapon against these infections.

2 Jun 2026

New funding supports cutting-edge research to combat cancers across South Texas

The University of Texas at San Antonio (UT San Antonio) and its academic health center, UT Health San Antonio, recently received over $2.7 million in new academic and prevention awards from the Cancer Prevention and Research Institute of Texas (CPRIT) to further its mission of combating cancers across South Texas.

2 Jun 2026

Study finds serious blood-related side effects associated with antibody-drug conjugates

A major real-world study by University of California, Irvine pharmacy researchers has found serious blood-related side effects associated with antibody-drug conjugates, an increasingly important class of targeted cancer therapies.

2 Jun 2026

First-in-class cancer drug gamitrinib evaluated in phase 1 clinical trial

Cancer cells need large amounts of energy to survive and multiply. To produce that energy, they rely on structures inside the cell called mitochondria, often described as the cell's "powerhouse."

2 Jun 2026

City of Hope sets new standard for lifelong, research-driven cancer survivorship care

Supporting the growing number of Americans living with cancer has become one of the most urgent challenges in modern cancer care as more people live years or decades beyond a diagnosis.

2 Jun 2026

Machine learning tool predicts financial toxicity for cancer patients

Researchers at MUSC Hollings Cancer Center have developed a machine learning tool to identify cancer patients who may be at high risk for financial toxicity – the financial stress and hardship that can accompany a cancer diagnosis and treatment.

2 Jun 2026

Microenvironmental CTHRC1 protein promotes colorectal cancer tumor growth

A new research paper was published in Volume 17 of Oncotarget on May 20, 2026, titled "Microenvironmental CTHRC1 has a pro-tumorigenic role in colorectal cancer."

2 Jun 2026

Novel theranostic approach targets aggressive neuroendocrine prostate cancer

A novel theranostic approach that targets RET -- a newly identified biomarker for neuroendocrine prostate cancer enables high-contrast PET imaging and effective, safe treatment for this highly aggressive malignancy.

2 Jun 2026

GLP-1 medications linked to lower breast cancer risk in women

A retrospective analysis of more than 110,000 women between the ages of 45 and 80 found that those who took GLP-1 medications were about 30 percent less likely to develop breast cancer than those who did not take GLP-1 medications, according to research presented today at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting (Abstract 10506) by Elizabeth McDonald, MD, PhD, a professor of Radiology in the University of Pennsylvania Perelman School of Medicine and a practicing breast radiologist at Penn's Abramson Cancer Center.

2 Jun 2026

Stem cell transplantation is the most cost-effective sickle cell treatment

Stem cell transplantation is the most cost-effective option for long-term care of sickle cell disease in adults when compared with gene therapy and standard of care treatment, according to new research published in Blood.

2 Jun 2026

Lifestyle habits predict long-term health better than cancer treatment history

Healthy lifestyle habits are crucial for childhood cancer survivors, reducing risks of chronic conditions and improving quality of life more than treatments.

2 Jun 2026